To the editor: Author reply; Nakano et al. Clin Chem Lab Med 2006;44(5):522-532 [4]

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 2, 2007, Pages 266-267

  Nakano, Takanari ^a   Komoda, Tsugikazu ^a   Nagata, Atsuo ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b YAMASA CORPORATION   (Japan)

Author keywords

Free light chain; Immunoassay

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN M;

DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; LETTER; MONOCLONAL IMMUNOGLOBULINEMIA; PRIORITY JOURNAL;

EID: 33847164543     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.054     Document Type: Letter

References (8)

1. Robson E, Mead G, Bradwell A. To the Editor: In reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522-532. Clin Chem Lab Med 2006;45:264-5.
2. Nakano T, Miyazaki S, Takahashi H, Matsumori A, Maruyama T, Komoda T, et al. Immunochemical quantification of free immunoglobulin light chains from an analytical perspective. Clin Chem Lab Med 2006;44:522-32.
3. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-80.
4. Tate JR, Gill D, Cobcroft R, Hickman PE. Practical considerations for the measurement of free light chains in serum. Clin Chem 2003;49:1252-7.
5. Tate JR, Mollee P, Dimeski G, Carter AC, Gill D. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Clin Chim Acta 2007. In press, doi:10.1016/j.cca.2006.07. 011.
6. Le Bricon T, Bengoufa D, Benlakehal M, Bousquet B, Erlich D. Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma. Clin Biochem 2002;35:565-7.
7. Rajkumar SV, Kyle RA, Therneau TM, Clark RJ, Bradwell AR, Melton LJ III, et al. Presence of monoclonal free light chains in serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Br J Haematol 2004;127:308-10.
8. Smith A, Wisloff F, Samson D. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 2006;132:410-51.